These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

741 related articles for article (PubMed ID: 34054944)

  • 1. Diagnostic and Therapeutic Potential of Exosomal MicroRNAs for Neurodegenerative Diseases.
    He M; Zhang HN; Tang ZC; Gao SG
    Neural Plast; 2021; 2021():8884642. PubMed ID: 34054944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomal microRNAs as diagnostic biomarkers and therapeutic applications in neurodegenerative diseases.
    Sataer X; Qifeng Z; Yingying Z; Chunhua H; Bingzhenga F; Zhiran X; Wanli L; Yuwei Y; Shuangfeng C; Lingling W; Hongri H; Jibing C; Xiaoping R; Hongjun G
    Neurol Res; 2023 Mar; 45(3):191-199. PubMed ID: 36184105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA Alteration, Application as Biomarkers, and Therapeutic Approaches in Neurodegenerative Diseases.
    Nguyen TPN; Kumar M; Fedele E; Bonanno G; Bonifacino T
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Dysregulated microRNA Biogenesis Machinery and microRNA Sorting on Neurodegenerative Diseases.
    Weng YT; Chang YM; Chern Y
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Biomarkers and Their Implications for the Early Diagnosis of Selected Neurodegenerative Diseases.
    Doroszkiewicz J; Groblewska M; Mroczko B
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases.
    Sheinerman KS; Toledo JB; Tsivinsky VG; Irwin D; Grossman M; Weintraub D; Hurtig HI; Chen-Plotkin A; Wolk DA; McCluskey LF; Elman LB; Trojanowski JQ; Umansky SR
    Alzheimers Res Ther; 2017 Nov; 9(1):89. PubMed ID: 29121998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative Diseases.
    Gentile G; Morello G; La Cognata V; Guarnaccia M; Conforti FL; Cavallaro S
    J Pers Med; 2022 May; 12(5):. PubMed ID: 35629192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights into the role of microRNAs and long noncoding RNAs in most common neurodegenerative diseases.
    Maniati MS; Maniati M; Yousefi T; Ahmadi-Ahangar A; Tehrani SS
    J Cell Biochem; 2019 Jun; 120(6):8908-8918. PubMed ID: 30663117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Causes and Consequences of MicroRNA Dysregulation in Neurodegenerative Diseases.
    Tan L; Yu JT; Tan L
    Mol Neurobiol; 2015; 51(3):1249-62. PubMed ID: 24973986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Sex Perspective in Neurodegenerative Diseases: microRNAs as Possible Peripheral Biomarkers.
    Piscopo P; Bellenghi M; Manzini V; Crestini A; Pontecorvi G; Corbo M; Ortona E; Carè A; Confaloni A
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurodegenerative Disorders Treatment: The MicroRNA Role.
    Ridolfi B; Abdel-Haq H
    Curr Gene Ther; 2017; 17(5):327-363. PubMed ID: 29357791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA biomarkers as next-generation diagnostic tools for neurodegenerative diseases: a comprehensive review.
    Azam HMH; Rößling RI; Geithe C; Khan MM; Dinter F; Hanack K; Prüß H; Husse B; Roggenbuck D; Schierack P; Rödiger S
    Front Mol Neurosci; 2024; 17():1386735. PubMed ID: 38883980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential of Therapeutic Small Molecules in Apoptosis Regulation in the Treatment of Neurodegenerative Diseases: An Updated Review.
    Dailah HG
    Molecules; 2022 Oct; 27(21):. PubMed ID: 36364033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA (miRNA) as a biomarker for diagnosis, prognosis, and therapeutics molecules in neurodegenerative disease.
    Alkhazaali-Ali Z; Sahab-Negah S; Boroumand AR; Tavakol-Afshari J
    Biomed Pharmacother; 2024 Aug; 177():116899. PubMed ID: 38889636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Commonalities in Biological Pathways, Genetics, and Cellular Mechanism between Alzheimer Disease and Other Neurodegenerative Diseases: An In Silico-Updated Overview.
    Ahmad K; Baig MH; Mushtaq G; Kamal MA; Greig NH; Choi I
    Curr Alzheimer Res; 2017; 14(11):1190-1197. PubMed ID: 28164765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miRNAs as biomarkers of neurodegenerative disorders.
    Viswambharan V; Thanseem I; Vasu MM; Poovathinal SA; Anitha A
    Biomark Med; 2017 Feb; 11(2):151-167. PubMed ID: 28125293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial dynamics, a key executioner in neurodegenerative diseases.
    Panchal K; Tiwari AK
    Mitochondrion; 2019 Jul; 47():151-173. PubMed ID: 30408594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurodegenerative Disorders of Alzheimer, Parkinsonism, Amyotrophic Lateral Sclerosis and Multiple Sclerosis: An Early Diagnostic Approach for Precision Treatment.
    Pathak N; Vimal SK; Tandon I; Agrawal L; Hongyi C; Bhattacharyya S
    Metab Brain Dis; 2022 Jan; 37(1):67-104. PubMed ID: 34719771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Panoramic Visualization of Circulating MicroRNAs Across Neurodegenerative Diseases in Humans.
    Brennan S; Keon M; Liu B; Su Z; Saksena NK
    Mol Neurobiol; 2019 Nov; 56(11):7380-7407. PubMed ID: 31037649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomerase reverse transcriptase and neurodegenerative diseases.
    Yu X; Liu MM; Zheng CY; Liu YT; Wang Z; Wang ZY
    Front Immunol; 2023; 14():1165632. PubMed ID: 37063844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.